Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 4Completed 4Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 38Lung Neoplasms 9Adenocarcinoma of Lung 9NSCLC 5Brain Neoplasms 5Adenocarcinoma, Bronchiolo-Alveolar 3Neoplasms 2Adenocarcinoma 2Triple Negative Breast Neoplasms 1Skin Neoplasms 1Non-squamous Non-small Cell Lung Cancer 1Non-Small-Cell Lung 1Liver Neoplasms 1Gastrointestinal Neoplasms 1Gallbladder Neoplasms 1Esophageal Neoplasms 1EGFR Tyrosine Kinase Inhibitors Plus VEGFR Inhibitors 1EGFR Mutation Positive Non-small Cell Lung Cancer 1Drug-Related Side Effects and Adverse Reactions 1Breast Neoplasms 1Advanced Stage Non Small Cell Lung Cancer 1Advanced Non-small Cell Lung Cancer 1Advanced NSCLC With EGFR Mutation 1

Interventions

Cisplatin 32Paclitaxel 29Radiotherapy 21Fluorouracil 20Radiation 12camrelizumab 11Oxaliplatin 11Docetaxel 11Carboplatin 10Capecitabine 9Esophagectomy 8Surgical Procedures, Operative 7Radiotherapy, Intensity-Modulated 6Leucovorin 6Endoscopic Mucosal Resection 6Drug Therapy 6apatinib 5Neoadjuvant Therapy 5Chemoradiotherapy 5nedaplatin 4S 1 (combination) 4Preoperative Exercise 4Irinotecan 4Endoscopy 4Cetuximab 4Albumin-Bound Paclitaxel 4pembrolizumab 3TP protocol 3Radiotherapy, Adjuvant 3Epirubicin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Esophageal Neoplasms × Gefitinib × Clear all
NCT01291823 2011-02-08

Gefitinib Combined With Radiotherapy in Elderly Patients With Esophageal Cancer

Zhejiang Cancer Hospital

Phase 2 Unknown
70 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡